TY  -  JOUR
AU  -  Barbara, Giussy
AU  -  Fabbri, Alice
AU  -  Mosconi, Paola
AU  -  Buggio, Laura
AU  -  Vercellini, Paolo
T1  -  A critical perspective on patient groups and industry funding
PY  -  2021
Y1  -  2021-03-01
DO  -  10.1701/3565.35453
JO  -  Recenti Progressi in Medicina
JA  -  Recenti Prog Med
VL  -  112
IS  -  3
SP  -  171
EP  -  172
PB  -  Il Pensiero Scientifico Editore
SN  -  2038-1840
Y2  -  2026/04/15
UR  -  http://dx.doi.org/10.1701/3565.35453
N2  -  Summary. Patient groups are non-profit organizations that focus on the needs of people affected by a specific disease. Over the years, patient groups have assumed an increasingly decisive role in the healthcare decision-making process, and may influence the governments’ decisions on key crucial health matters. Financial support for patient groups can come from different sources, including the pharmaceutical and medical device industries. Although patient groups may certainly benefit from drug companies economic support, in this commentary we address concerns regarding the presence of potential conflict of interests (COIs), which may affect the independence, objectivity, integrity and reputation of the organizations.
ER  -